SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Rigel Pharmaceuticals, Inc. (RIGL)
RIGL 35.20-2.6%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who started this subject1/7/2004 9:15:51 AM
From: mopgcw  Read Replies (1) of 566
 
someone is paying up for rigl pre-market, so fed them a chunk...strange

edit:RIGL target raised to $32 at CSFB 2004/01/07 08:18:05

19.10: CSFB names Outperform-rated Rigel Pharms as their top small-cap biotech stock pick for 2004, and raises their target to $32 from $26; firm expects key efficacy data in 2004 from two lead programs (SyK inhibitors for asthma/allergy, R803 small molecule HCV inhibitor) to keep the stock in the spotlight, and firm continues to believe that both programs have billion-dollar peak sales potential.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext